GB9911183D0 - Treatment of cancers - Google Patents

Treatment of cancers

Info

Publication number
GB9911183D0
GB9911183D0 GBGB9911183.3A GB9911183A GB9911183D0 GB 9911183 D0 GB9911183 D0 GB 9911183D0 GB 9911183 A GB9911183 A GB 9911183A GB 9911183 D0 GB9911183 D0 GB 9911183D0
Authority
GB
United Kingdom
Prior art keywords
cancers
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9911183.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmamar SA
Original Assignee
Pharmamar SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmamar SA filed Critical Pharmamar SA
Priority to GBGB9911183.3A priority Critical patent/GB9911183D0/en
Publication of GB9911183D0 publication Critical patent/GB9911183D0/en
Priority to MYPI20002107A priority patent/MY164077A/en
Priority to ARP000102321A priority patent/AR028476A1/en
Priority to SK1644-2001A priority patent/SK287580B6/en
Priority to PT06014005T priority patent/PT1716853E/en
Priority to DE60030554T priority patent/DE60030554T8/en
Priority to PL352931A priority patent/PL198185B1/en
Priority to AT00927584T priority patent/ATE338552T1/en
Priority to SI200031067T priority patent/SI1716853T1/en
Priority to CNA2007101863681A priority patent/CN101181272A/en
Priority to DK00927584T priority patent/DK1176964T3/en
Priority to ES06011784T priority patent/ES2294756T3/en
Priority to CA002373794A priority patent/CA2373794C/en
Priority to PT00927584T priority patent/PT1176964E/en
Priority to SI200030977T priority patent/SI1702618T1/en
Priority to SI200030905T priority patent/SI1176964T1/en
Priority to EP06014005A priority patent/EP1716853B9/en
Priority to CNB2005100091622A priority patent/CN100477993C/en
Priority to CZ20014081A priority patent/CZ301482B6/en
Priority to AU45975/00A priority patent/AU777417B2/en
Priority to TR2001/03819T priority patent/TR200103819T2/en
Priority to ES06014005T priority patent/ES2363064T3/en
Priority to AT06014005T priority patent/ATE500830T1/en
Priority to DK06011784T priority patent/DK1702618T3/en
Priority to NZ515423A priority patent/NZ515423A/en
Priority to PCT/GB2000/001857 priority patent/WO2000069441A1/en
Priority to AT06011784T priority patent/ATE375795T1/en
Priority to EP00927584A priority patent/EP1176964B8/en
Priority to HU0201187A priority patent/HU229866B1/en
Priority to IL14643400A priority patent/IL146434A0/en
Priority to UA2001128559A priority patent/UA74782C2/en
Priority to DK06014005.0T priority patent/DK1716853T3/en
Priority to EP06011784A priority patent/EP1702618B1/en
Priority to PT06011784T priority patent/PT1702618E/en
Priority to DE60045720T priority patent/DE60045720D1/en
Priority to KR1020017014479A priority patent/KR20020019914A/en
Priority to RU2001133467/15A priority patent/RU2266734C2/en
Priority to BR0010531-7A priority patent/BR0010531A/en
Priority to DE122008000013C priority patent/DE122008000013I1/en
Priority to DE60036826T priority patent/DE60036826T2/en
Priority to CN00809976A priority patent/CN1360503A/en
Priority to JP2000617900A priority patent/JP2002544231A/en
Priority to ES00927584T priority patent/ES2272279T3/en
Priority to MXPA01011562A priority patent/MXPA01011562A/en
Priority to IL146434A priority patent/IL146434A/en
Priority to NO20015516A priority patent/NO324564B1/en
Priority to BG106171A priority patent/BG65680B1/en
Priority to AU2005200180A priority patent/AU2005200180B9/en
Priority to CY20061101734T priority patent/CY1105818T1/en
Priority to US11/769,873 priority patent/US8119638B2/en
Priority to CY20081100059T priority patent/CY1107143T1/en
Priority to NL300337C priority patent/NL300337I2/en
Priority to LU91418C priority patent/LU91418I2/en
Priority to CY200800007C priority patent/CY2008007I2/en
Priority to FR08C0013C priority patent/FR08C0013I2/en
Priority to NO2008005C priority patent/NO2008005I1/en
Priority to CY20111100545T priority patent/CY1112753T1/en
Priority to JP2012105249A priority patent/JP5777562B2/en
Priority to HUS1500001C priority patent/HUS1500001I1/en
Priority to ARP170101288A priority patent/AR109456A2/en
Ceased legal-status Critical Current

Links

GBGB9911183.3A 1999-05-13 1999-05-13 Treatment of cancers Ceased GB9911183D0 (en)

Priority Applications (60)

Application Number Priority Date Filing Date Title
GBGB9911183.3A GB9911183D0 (en) 1999-05-13 1999-05-13 Treatment of cancers
MYPI20002107A MY164077A (en) 1999-05-13 2000-05-13 Compositions and uses of et743 for treating cancer
ARP000102321A AR028476A1 (en) 1999-05-13 2000-05-15 CANCER TREATMENT
SK1644-2001A SK287580B6 (en) 1999-05-13 2000-05-15 Use of ET743 in the preparation of medicament for the treatment of the human body cancer
PT06014005T PT1716853E (en) 1999-05-13 2000-05-15 Treatment of cancers of the human body using et743
DE60030554T DE60030554T8 (en) 1999-05-13 2000-05-15 USES OF ET743 FOR THE TREATMENT OF CANCER
PL352931A PL198185B1 (en) 1999-05-13 2000-05-15 Compositions and uses of et743 for treating cancer
AT00927584T ATE338552T1 (en) 1999-05-13 2000-05-15 USES OF ET743 TO TREAT CANCER
SI200031067T SI1716853T1 (en) 1999-05-13 2000-05-15 Treatment of cancers of the human body using ET743
CNA2007101863681A CN101181272A (en) 1999-05-13 2000-05-15 Compositions and uses of et743 for treating cancer
DK00927584T DK1176964T3 (en) 1999-05-13 2000-05-15 Use of ET743 for the treatment of cancer
ES06011784T ES2294756T3 (en) 1999-05-13 2000-05-15 USE OF ET743 IN COMBINATION THERAPY WITH DEXAMETASONE FOR THE TREATMENT OF CANCER.
CA002373794A CA2373794C (en) 1999-05-13 2000-05-15 Compositions and uses of et743 for treating cancer
PT00927584T PT1176964E (en) 1999-05-13 2000-05-15 Uses of et743 for treating cancer
SI200030977T SI1702618T1 (en) 1999-05-13 2000-05-15 Use of et743 in combination therapy with dexamethasone for treating cancer
SI200030905T SI1176964T1 (en) 1999-05-13 2000-05-15 Uses of et743 for treating cancer
EP06014005A EP1716853B9 (en) 1999-05-13 2000-05-15 Treatment of cancers of the human body using ET743
CNB2005100091622A CN100477993C (en) 1999-05-13 2000-05-15 Compositions and uses of et743 for treating cancer
CZ20014081A CZ301482B6 (en) 1999-05-13 2000-05-15 Compositions and use of ET743 for treating cancer
AU45975/00A AU777417B2 (en) 1999-05-13 2000-05-15 Compositions and uses of ET743 for treating cancer
TR2001/03819T TR200103819T2 (en) 1999-05-13 2000-05-15 ET743 compositions and uses in cancer treatment
ES06014005T ES2363064T3 (en) 1999-05-13 2000-05-15 TREATMENT OF HUMAN BODY CANCER USING ET743.
AT06014005T ATE500830T1 (en) 1999-05-13 2000-05-15 TREATING HUMAN CANCER WITH ET743
DK06011784T DK1702618T3 (en) 1999-05-13 2000-05-15 Use of ET743 in combination therapy with dexamethasone for the treatment of cancer
NZ515423A NZ515423A (en) 1999-05-13 2000-05-15 Compositions and uses of ET743 for treating cancer
PCT/GB2000/001857 WO2000069441A1 (en) 1999-05-13 2000-05-15 Compositions and uses of et743 for treating cancer
AT06011784T ATE375795T1 (en) 1999-05-13 2000-05-15 USE OF ET743 IN COMBINATION THERAPY WITH DEXAMETHASONE FOR THE TREATMENT OF CANCER
EP00927584A EP1176964B8 (en) 1999-05-13 2000-05-15 Uses of et743 for treating cancer
HU0201187A HU229866B1 (en) 1999-05-13 2000-05-15 Use of et743 in combination therapy with dexamethasone for treating cancer
IL14643400A IL146434A0 (en) 1999-05-13 2000-05-15 Pharmaceutical compositions containing ecteinascidin 743
UA2001128559A UA74782C2 (en) 1999-05-13 2000-05-15 Et743 in preparation of medicament for treatment of human cancer and method for treatment
DK06014005.0T DK1716853T3 (en) 1999-05-13 2000-05-15 Treatment of human body cancer using ET743
EP06011784A EP1702618B1 (en) 1999-05-13 2000-05-15 Use of et743 in combination therapy with dexamethasone for treating cancer
PT06011784T PT1702618E (en) 1999-05-13 2000-05-15 Use of et743 in combination therapy with dexamethasone for treating cancer
DE60045720T DE60045720D1 (en) 1999-05-13 2000-05-15 Treatment of cancer in humans with ET743
KR1020017014479A KR20020019914A (en) 1999-05-13 2000-05-15 Composition and uses of et743 for treating cancer
RU2001133467/15A RU2266734C2 (en) 1999-05-13 2000-05-15 Composition and utilization of et743 for malignant tumor treatment
BR0010531-7A BR0010531A (en) 1999-05-13 2000-05-15 Compositions and uses of et743 for cancer treatment
DE122008000013C DE122008000013I1 (en) 1999-05-13 2000-05-15 USE OF ET743 IN COMBINATION THERAPY WITH DEXAMETHASONE FOR THE TREATMENT OF CANCER
DE60036826T DE60036826T2 (en) 1999-05-13 2000-05-15 USE OF ET743 IN COMBINATION THERAPY WITH DEXAMETHASONE FOR THE TREATMENT OF CANCER
CN00809976A CN1360503A (en) 1999-05-13 2000-05-15 Compositions and uses of ET 743 for treating cancer
JP2000617900A JP2002544231A (en) 1999-05-13 2000-05-15 Use of a composition and ET743 to treat cancer
ES00927584T ES2272279T3 (en) 1999-05-13 2000-05-15 USE OF ET-743 COMPOUND FOR THE TREATMENT OF CANCER.
MXPA01011562A MXPA01011562A (en) 1999-05-13 2000-05-15 Compositions and uses of et743 for treating cancer.
IL146434A IL146434A (en) 1999-05-13 2001-11-11 Pharmaceutical compositions containing ecteinascidin 743
NO20015516A NO324564B1 (en) 1999-05-13 2001-11-12 Use of ET743 for the manufacture of a drug for the treatment of cancer
BG106171A BG65680B1 (en) 1999-05-13 2001-12-03 Use of et743 for treating cancer
AU2005200180A AU2005200180B9 (en) 1999-05-13 2005-01-14 Compositions and uses of ET743 for treating cancer
CY20061101734T CY1105818T1 (en) 1999-05-13 2006-11-30 USES OF ET743 IN THE THERAPEUTIC TREATMENT OF CANCER
US11/769,873 US8119638B2 (en) 1999-05-13 2007-06-28 Compositions and uses of ET743 for treating cancer
CY20081100059T CY1107143T1 (en) 1999-05-13 2008-01-16 USE OF ET743 IN COMBINATION THERAPY WITH DEXAMETHAZONE FOR THE THERAPEUTIC TREATMENT OF CANCER
NL300337C NL300337I2 (en) 1999-05-13 2008-02-22 Use of ET-743 in combination therapy with dexamethasone for the treatment of cancer
LU91418C LU91418I2 (en) 1999-05-13 2008-03-10 YONDELIS-trabectedin
CY200800007C CY2008007I2 (en) 1999-05-13 2008-04-07 USE OF ET743 IN COMBINATION THERAPY WITH DEXAMETHAZONE FOR THE THERAPEUTIC TREATMENT OF CANCER
FR08C0013C FR08C0013I2 (en) 1999-05-13 2008-04-16 USE OF ET743 IN COMBINATION THERAPY WITH DEXAMETHASONE TO TREAT CANCER
NO2008005C NO2008005I1 (en) 1999-05-13 2008-05-16 trabectedin
CY20111100545T CY1112753T1 (en) 1999-05-13 2011-06-08 HUMAN BODY CANCER TREATMENT BY USE TO743
JP2012105249A JP5777562B2 (en) 1999-05-13 2012-05-02 Use of compositions and ET743 for treating cancer
HUS1500001C HUS1500001I1 (en) 1999-05-13 2015-01-06 Use of et743 in combination therapy with dexamethasone for treating cancer
ARP170101288A AR109456A2 (en) 1999-05-13 2017-05-15 USE OF ET743 FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF A HUMAN PATIENT AFFECTED BY CANCER THROUGH COMBINATION THERAPY

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9911183.3A GB9911183D0 (en) 1999-05-13 1999-05-13 Treatment of cancers

Publications (1)

Publication Number Publication Date
GB9911183D0 true GB9911183D0 (en) 1999-07-14

Family

ID=10853439

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9911183.3A Ceased GB9911183D0 (en) 1999-05-13 1999-05-13 Treatment of cancers

Country Status (4)

Country Link
CN (1) CN101181272A (en)
AR (1) AR109456A2 (en)
ES (1) ES2363064T3 (en)
GB (1) GB9911183D0 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112574234B (en) * 2019-09-27 2022-05-24 江苏恒瑞医药股份有限公司 Preparation method of ecteinascidin derivative

Also Published As

Publication number Publication date
AR109456A2 (en) 2018-12-12
CN101181272A (en) 2008-05-21
ES2363064T3 (en) 2011-07-19

Similar Documents

Publication Publication Date Title
HK1161893A1 (en) Treatment of coal
SI1176964T1 (en) Uses of et743 for treating cancer
IL148579A0 (en) Oncolytic combinations for the treatment of cancer
GB9901838D0 (en) Slurry treatment
AU9402401A (en) Treatment of cancers
IL149281A0 (en) Treatment of cancer
AU5552400A (en) Treatment of cancer
GB9819999D0 (en) Treatment of cancer
NZ514016A (en) Treatment of osteoarthritis
GB9911183D0 (en) Treatment of cancers
GB9927005D0 (en) Treatment of cancers
GB9918534D0 (en) Treatment of cancers
GB9911346D0 (en) Treatment of cancers
GB9804361D0 (en) Cancer treatment
GB0025209D0 (en) Treatment of cancers
GB9927006D0 (en) Aplidine treatment of cancers
GB9901310D0 (en) Methods of treatment
GB9917181D0 (en) Methods of treatment
GB9908176D0 (en) Cancer treatment
GB9927106D0 (en) Cancer treatment
SI1242060T1 (en) Treatment of metastatic disease
GB0008161D0 (en) Treatment of cancer
GB9926359D0 (en) Treatment of alopecia
GB9924958D0 (en) Treatment of neuropathy
IL152925A0 (en) Treatment of neuropathy

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)